Related Experiment Video
Updated: Jul 6, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Involvement of amlodipine, diazoxide, and glibenclamide in development of morphine tolerance in mice
Omid Khalilzadeh1, Mehdi Anvari, Azita Khalilzadeh
1Department of Pharmacology and Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
In this study, the effects of the calcium channel blocker (amlodipine), potassium channel opener (diazoxide), and potassium channel blocker (glibenclamide) on the development of morphine-induced tolerance in the formalin test was investigated. During development of tolerance to morphine, intraperitoneal (i.p.) administration of different doses of amlodipine (5, 7.5 and 10 mg/kg) or diazoxide (1, 5 and 10 mg/kg) in combination with morphine (20 and 30 mg/kg) increased tolerance in the first and second phase of the test. However, glibenclamide (2.5, 5, and 10 mg/kg) decreased morphine tolerance in the second phase of formalin test. It is concluded that calcium and potassium channel mechanisms may be involved in the morphine tolerance.
Insights
This study investigated how calcium and potassium channel modulators affect morphine tolerance. Amlodipine and diazoxide worsened morphine tolerance, while glibenclamide reduced it, suggesting channel involvement in opioid tolerance.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Management
Background:
- Opioid tolerance, a common issue in pain management, necessitates understanding its underlying mechanisms.
- Calcium and potassium channels are implicated in neuronal excitability and drug action.
Purpose of the Study:
- To investigate the role of calcium and potassium channels in the development of morphine-induced tolerance.
- To examine the effects of amlodipine, diazoxide, and glibenclamide on morphine tolerance in a preclinical pain model.
Main Methods:
- The study utilized the formalin test to assess pain and tolerance.
- Morphine was administered intraperitoneally (i.p.) in combination with varying doses of amlodipine, diazoxide, or glibenclamide.
- Behavioral responses were measured in the first and second phases of the formalin test.
Main Results:
- Co-administration of amlodipine (5-10 mg/kg) or diazoxide (1-10 mg/kg) with morphine potentiated morphine tolerance in both phases of the formalin test.
- Glibenclamide (2.5-10 mg/kg) significantly decreased morphine tolerance in the second phase of the formalin test.
Conclusions:
- Calcium channel blockade (amlodipine) and potassium channel opening (diazoxide) appear to enhance morphine tolerance.
- Potassium channel blockade (glibenclamide) may attenuate morphine tolerance, particularly in later stages.
- These findings suggest that calcium and potassium channel modulations are involved in the development of morphine tolerance.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Drug Abuse and Addiction: Pharmacological Phenomena

